A @-month double-blind sham-surgery-controlled trial assessing adeno-associated virus type @ ( AAV@ ) - neurturin injected into the putamen bilaterally failed to meet its primary endpoint , but showed positive results for the primary endpoint in the subgroup of subjects followed for @ months and for several secondary endpoints .